Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis. - Roberts BR; Lim NK; McAllum EJ; Donnelly PS; Hare DJ; Doble PA; Turner BJ; Price KA; Lim SC; Paterson BM; Hickey JL; Rhoads TW; et al. (The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014)